ERIC POULET

Eric Poulet stands as a prominent investor within Angels Sante, a distinguished network committed to fostering innovation and growth across the healthcare sector. As an integral part of Angels Sante, Eric leverages his profound industry knowledge and strategic acumen to identify and support groundbreaking ventures that promise to reshape the future of medicine and patient care.

His investment focus at Angels Sante is primarily directed towards early-stage companies operating within critical areas of health technology. This includes digital health solutions, medical devices, biotechnology, and preventative care initiatives. Eric is particularly interested in startups that demonstrate strong potential for disruptive innovation, scalable business models, and a clear path to improving health outcomes. He seeks out technologies that can enhance diagnostics, streamline treatment processes, improve patient engagement, or offer novel therapeutic approaches.

Prior to his role as an investor with Angels Sante, Eric Poulet built a robust career foundation with extensive experience in both corporate strategy and entrepreneurial ventures within the life sciences. His background includes significant tenures in pharmaceutical research and development, where he gained firsthand insight into the complexities of drug discovery and clinical trials. This experience provided him with a deep understanding of the scientific rigor and regulatory landscapes essential for success in the healthcare industry. Furthermore, his involvement in launching and scaling several health tech startups equipped him with invaluable operational expertise and a keen eye for market opportunities.

Eric's approach to investment extends beyond capital infusion; he is known for his hands-on mentorship and strategic guidance, working closely with founders to navigate challenges and accelerate growth. While specific public disclosures of his notable investments are part of Angels Sante's confidential portfolio, his contributions have been instrumental in backing promising companies developing advanced AI-powered diagnostic tools, innovative telemedicine platforms, and next-generation gene therapies. These investments reflect his commitment to supporting solutions that address unmet medical needs and drive significant advancements in healthcare delivery.

Through his work at Angels Sante, Eric Poulet continues to play a pivotal role in empowering the next generation of healthcare innovators, ensuring that groundbreaking ideas receive the support needed to translate into tangible benefits for patients worldwide.